Pacira reported $1.54B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Astellas Pharma JPY 3.34T 3.71B Jun/2025
Bristol-Myers Squibb USD 94.68B 2.25B Jun/2025
Ironwood Pharmaceuticals USD 351.3M 38.22M Dec/2024
J&J USD 193.67B 13.57B Mar/2025
Ligand Pharmaceuticals USD 948.6M 43.17M Jun/2025
Novo Nordisk 482.15B 7.01B Jun/2025
Pacira USD 1.54B 49.41M Jun/2025
Perrigo USD 10.09B 334.3M Jun/2025
Pfizer USD 206.1B 1.93B Jun/2025
Supernus Pharmaceuticals USD 1.38B 35.11M Jun/2025
Teva Pharmaceutical Industries USD 40.13B 1.72B Jun/2025
Xeris Pharmaceuticals USD 334.69M 11.63M Jun/2025
Zoetis USD 14.48B 381M Jun/2025